- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
ICL Group Reports Solid Q4 Earnings, Focuses on Specialty Growth
Company met annual guidance, sees opportunities in Specialty Crop Nutrition and Specialty Food Solutions
Published on Feb. 22, 2026
Got story updates? Submit your updates here. ›
ICL Group (NYSE:ICL) reported strong Q4 2025 results, meeting its annual guidance target with $1 billion in 'specialty-driven EBITDA'. The company saw sales growth across all four segments and highlighted strategic acquisitions and portfolio actions to fund its targeted growth engines in Specialty Crop Nutrition and Specialty Food Solutions. Management also discussed ongoing challenges like raw material inflation and currency headwinds, but expressed optimism about the company's transformation and future prospects.
Why it matters
As a global specialty minerals and chemicals company, ICL Group's performance and strategic priorities provide insights into trends and dynamics in key industries like agriculture, food ingredients, and industrial chemicals. The company's ability to navigate macroeconomic pressures while investing in high-growth specialty segments will be closely watched by investors and analysts.
The details
ICL reported Q4 2025 sales of $1.701 billion, up 6% year-over-year, with consolidated adjusted EBITDA of $380 million, up 10%. The company cited pricing as a meaningful contributor, though volumes declined. ICL also highlighted its acquisition of Bartek Ingredients, a leader in food-grade malic and fumaric acids, as deepening its specialty food portfolio. Management discussed portfolio optimization actions to fund its Specialty Crop Nutrition and Specialty Food Solutions growth engines, including an MOU with Israel on the Dead Sea concession.
- ICL reported Q4 2025 results on February 18, 2026.
The players
ICL Group
A global specialty minerals and chemicals company headquartered in Tel Aviv, Israel. ICL has evolved from state-driven mineral extraction operations in the Negev and Dead Sea region to a publicly traded entity on the New York Stock Exchange.
Elad Aharonson
CEO of ICL Group.
Aviram Lahav
CFO of ICL Group.
Bartek Ingredients
A global leader in food-grade malic and fumaric acids that ICL acquired to deepen its specialty food portfolio.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident (San Francisco Chronicle)
“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”
— Gordon Edgar, grocery employee (Instagram)
What’s next
The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.
The takeaway
This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.
St. Louis top stories
St. Louis events
Mar. 4, 2026
Voodoo Allman Brothers BandMar. 11, 2026
Voodoo CSNY



